anonymous
Guest
anonymous
Guest
- Our boss’ distinguish recorded at helm:
- Stock price down from $9.55 to $0.97. ~90%
- Never bought a share on open market, sold hundreds of thousands of shares.
- Multiple Debt deals.
- May not reach data readouts despite overwhelmingly early positive data signals.
- Trials cancelled, multiple phase 3 trials delayed.
- Stock currently under NASDAQ requirements
- Multiple unforced errors, like European Assay delay
- Despite all this getting 95% bonus from board, tons of equity (422,000 shares this year alone!), and not fired for cause with clawback.
- Given an agent that works in multiple indications, still has not added a single indication from when he took over in 05/2021.